SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Landec Corp/CA – ‘8-K’ for 5/6/19

On:  Monday, 5/6/19, at 9:46pm ET   ·   As of:  5/7/19   ·   For:  5/6/19   ·   Accession #:  1628280-19-5963   ·   File #:  0-27446

Previous ‘8-K’:  ‘8-K’ on / for 4/3/19   ·   Next:  ‘8-K’ on / for 5/24/19   ·   Latest:  ‘8-K’ on 4/30/24 for 4/29/24   ·   18 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/07/19  Landec Corp/CA                    8-K:5,9     5/06/19    2:39K                                    Workiva Inc Wde… FA01/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     17K 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML     10K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 6, 2019
  
LANDEC CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of incorporation)
  
 
94-3025618
(Commission file number)
 
(IRS Employer Identification No.)
  
 5201 Great America Parkway, Suite 232, Santa Clara, California
(Address of principal executive offices)
(Zip Code)
 
(650) 306-1650
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
 ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock
LNDC
The NASDAQ Global Select Market




Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Effective May 6, 2019, the Board of Directors of Landec Corporation (the “Company”) adopted an amendment to Section 2.5(a) of the Company’s By-Laws (the “Amendment”). The Amendment extends, to 5:00 p.m. PT on May 29, 2019, the date by which nominations of persons for election to the Board and/or business proposals may be submitted with respect to the 2019 Annual Meeting of Stockholders and included in the Company’s related proxy statement and form of proxy. A copy of the Amendment is attached hereto as Exhibit 3.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
Description
Amendment to the By-Laws of the Company.

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: May 7, 2019
 
 
LANDEC CORPORATION
 
 
 
 
 
 
 
 
 
 
By:
 
 
 
 
 
 
Vice President of Finance and Administration and Chief Financial Officer
 
 
 
 


- 2 -





EXHIBIT INDEX


Exhibit No.
Description
3.1
Amendment to the By-Laws of the Company.





- 3 -



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
5/29/19None on these Dates
Filed as of:5/7/19
Filed on / For Period End:5/6/19
 List all Filings 


18 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/20/24  Lifecore Biomedical, Inc./DE      10-K        5/28/23  138:75M
 6/06/23  Lifecore Biomedical, Inc./DE      S-1/A                  2:365K                                   Workiva Inc Wde… FA01/FA
 6/02/23  Lifecore Biomedical, Inc./DE      10-Q        2/26/23   63:8.3M
 4/06/23  Lifecore Biomedical, Inc./DE      S-1                    4:527K                                   Workiva Inc Wde… FA01/FA
 4/06/23  Lifecore Biomedical, Inc./DE      S-8         4/06/23    4:97K
 3/16/23  Lifecore Biomedical, Inc./DE      10-Q       11/27/22   62:6.8M
 3/16/23  Lifecore Biomedical, Inc./DE      10-Q/A      8/28/22   69:7.6M
 3/16/23  Lifecore Biomedical, Inc./DE      10-K/A      5/29/22  129:20M
10/07/22  Lifecore Biomedical, Inc./DE      10-Q        8/28/22   60:5.8M
 9/14/22  Lifecore Biomedical, Inc./DE      10-K        5/29/22  112:17M
 4/07/22  Lifecore Biomedical, Inc./DE      10-Q        2/27/22   64:8.1M
 1/07/22  Lifecore Biomedical, Inc./DE      10-Q       11/28/21   61:6.9M
10/05/21  Lifecore Biomedical, Inc./DE      10-Q        8/29/21   60:5.8M
 7/29/21  Lifecore Biomedical, Inc./DE      10-K        5/30/21  107:13M
 4/08/21  Lifecore Biomedical, Inc./DE      10-Q        2/28/21   70:7.4M
 1/07/21  Lifecore Biomedical, Inc./DE      10-Q       11/29/20   72:7.4M
10/07/20  Lifecore Biomedical, Inc./DE      10-Q        8/30/20   72:7.1M
 8/14/20  Lifecore Biomedical, Inc./DE      10-K        5/31/20  107:16M
Top
Filing Submission 0001628280-19-005963   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 5:18:33.2pm ET